138 related articles for article (PubMed ID: 4388267)
21. [Clomethacillin. Synthesis and antibacterial properties].
Rudzit EA; Pleshakov MG; Radkevich TP; Kulikova DA; Avidon VV
Antibiotiki; 1974 Oct; 19(10):887-90. PubMed ID: 4218940
[No Abstract] [Full Text] [Related]
22. [Bacteriological study on clindamycin-2-palmitate (author's transl)].
Ono H; Otsuki M; Nakazawa S
Jpn J Antibiot; 1973 Aug; 26(4):321-4. PubMed ID: 4582578
[No Abstract] [Full Text] [Related]
23. Biological characterization of prasinomycin, a phosphorus-containing antibiotic.
Meyers E; Miraglia GJ; Smith DA; Basch HI; Pansy FE; Trejo WH; Donovick R
Appl Microbiol; 1968 Apr; 16(4):603-8. PubMed ID: 5647519
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure.
Zielnik-Jurkiewicz B; Bielicka A
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2129-33. PubMed ID: 26454530
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
[TBL] [Abstract][Full Text] [Related]
26. The gram-positive cocci: III. Resistance to antibiotics.
Musher DM
Hosp Pract (Off Ed); 1988 May; 23(5):105-7, 111-2, 117-8 passim. PubMed ID: 3131351
[No Abstract] [Full Text] [Related]
27. A54145 a new lipopeptide antibiotic complex: microbiological evaluation.
Counter FT; Allen NE; Fukuda DS; Hobbs JN; Ott J; Ensminger PW; Mynderse JS; Preston DA; Wu CY
J Antibiot (Tokyo); 1990 Jun; 43(6):616-22. PubMed ID: 2380110
[TBL] [Abstract][Full Text] [Related]
28. [Protective effect of placental lysozyme on experimental infections in mice induced by Clostridium tetani, Staphylococcus aureus and Diplococcus pneumoniae].
Suyama T; Oguro Y; Doi T; Izaka K
Jpn J Antibiot; 1969 Aug; 22(4):287-98. PubMed ID: 4390930
[No Abstract] [Full Text] [Related]
29. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
[No Abstract] [Full Text] [Related]
30. Clinical evaluation of cephaloridine.
Steigbigel NH; Kislak JW; Tilles JG; Finland M
Arch Intern Med; 1968 Jan; 121(1):24-38. PubMed ID: 5635071
[No Abstract] [Full Text] [Related]
31. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
[TBL] [Abstract][Full Text] [Related]
32. Use of vancomycin in pediatrics.
Dehority W
Pediatr Infect Dis J; 2010 May; 29(5):462-4. PubMed ID: 20431384
[No Abstract] [Full Text] [Related]
33. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
Kondo M; Oishi T; Tsuchiya K
J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
[No Abstract] [Full Text] [Related]
34. LL-AV290, a new antibiotic. II. Antibacterial efficacy in mice and in vitro.
Redin GS; Dornbush AC
Antimicrob Agents Chemother (Bethesda); 1968; 8():246-8. PubMed ID: 5735367
[No Abstract] [Full Text] [Related]
35. [Current data on antibiotic sensitivity of microflora causing otorhinolaryngologic diseases. 1. Antibiotic sensitivity of Staphylococci and Streptococci].
Povolotskiĭ IaL
Zh Ushn Nos Gorl Bolezn; 1979; (1):83-9. PubMed ID: 375612
[No Abstract] [Full Text] [Related]
36. Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin.
Kondo M; Ishifuji K; Tsuchiya K; Goto S; Kuwahara S
Antimicrob Agents Chemother; 1973 Aug; 4(2):156-9. PubMed ID: 4790936
[TBL] [Abstract][Full Text] [Related]
37. ["Bacteriostatic test"- a method of the study of microbial sensitivity to antibiotics].
Rachinskiĭ SV; Zakhidova EKh
Lab Delo; 1974; (12):732-5. PubMed ID: 4140963
[No Abstract] [Full Text] [Related]
38. [Bacteriological studies on prolinomethyltetracycline].
Kawarajo K; Onoda M; Nomiya B; Abe M
Jpn J Antibiot; 1971 Dec; 24(6):249-55. PubMed ID: 4946846
[No Abstract] [Full Text] [Related]
39. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities.
Liang JH; Li XL; Wang H; An K; Wang YY; Xu YC; Yao GW
Eur J Med Chem; 2012 Mar; 49():289-303. PubMed ID: 22301216
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial therapy. II. Some considerations of specific treatment of selected bacteremic infections.
McHenry MC
Cleve Clin Q; 1970 Jan; 37(1):51-8. PubMed ID: 5415868
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
